Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.11.17.688929

Anxious vision: Trait-like visual cortical hyperactivity in trait anxiety

Wu, Z.·You, Y.·Brown, J. A.·Dolan, R. J.·Li, W.
View original source ↗Export metadata ↓

Abstract

Sensory processing varies across individuals, often manifesting as distinct traits. Some traits, particularly sensory hypersensitivity, even to basic non-valenced stimuli, are closely linked to emotional traits and implicated in a diversity of psychiatric disorders. Extant theories attribute this sensory-emotion linkage to limbic and prefrontal modulation, but empirical support remains limited. Meanwhile, it is increasingly recognized that sensory cortex supports flexible, value-based processing beyond labeled-line sensory analysis. Assaying early visual cortical activity (using visual evoked potentials/VEPs) across four high-density electroencephalogram (hd-EEG) experiments, involving three independent samples (N = 150) and repeated assessments (up to three waves), we identify a reliable and generalizable pattern of visual cortical hyperactivity related to high trait anxiety. Notably, this effect was specific to the parvocellular (vs. magnocellular) pathway, emerging as early as 46 ms and localized to V1. Underscoring its trait-like stability, the effect was reproducible across different arousal states, neutral and negative stimuli, extended time intervals, and varied experimental paradigms. Moreover, its ecological validity was affirmed by its presence in response to both basic low-level stimuli (Gabor patches) and complex real-world images. Crucially, an excitation-inhibition (E/I) ratio (indexed by the resting-state EEG aperiodic exponent; 1/f slope) predicted parvocellular VEP magnitude in subjects with low but not high trait anxiety, suggesting disrupted E/I modulation in trait anxiety underpins this hyperactivity. We conclude that in trait anxiety, early visual processing deviates from strict "fidelity" to physical-world input or mere "subservience" to top-down modulation, instead adapting to an individuals biological propensity at the earliest processing stage. HighlightsO_LIHyperactivity in primary visual cortex is stable, trait-like C_LIO_LIIt occurs as early as 46 ms post-stimulus, during initial feedforward sweep C_LIO_LIIt covaries with trait anxiety, a key personality factor and risk predisposition for psychiatric disorders C_LIO_LIIt is related to disrupted excitation-inhibition modulation of visual cortex in trait anxiety C_LI

Source connections

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wu, Z., You, Y., Brown, J. A., Dolan, R. J., Li, W.. 2025-11-18. Anxious vision: Trait-like visual cortical hyperactivity in trait anxiety. https://doi.org/10.1101/2025.11.17.688929

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗